• News & Events
  • News
  • Invited keynote lecture on ATRIVAs antiviral MEK inhibitor technology presented at the Annual Meeting of the German Pharmaceutical Society (DPhG)

ATRIVA Therapeutics Gewinner des S4L Venture Cups 2016

In Berlin wurden Anfang März die Gewinner der Konzeptphase des Science4Life Venture Cups gekürt. Lesen Sie hier den vollständigen Artikel http://www.transkript.de/nachrichten/wirtschaft/2016-01/s4l-kuert-die-besten-konzepte.html

Media Coverage


Events & Presentations

Please note that, due to the current coronavirus crisis, many conferences have been canceled or postponed.

  • September 21-24, 2020 - BioPharm America Digital. Dr. Björn Cochlovius, VP Business Development, will represent the Company and be available for networking and one-on-one meetings.
  • October 26-29, 2020 - BIO-Europe Digital.

Feel free to contact us any time.


Atriva Therapeutics GmbH
Eisenbahnstr. 1, 72072 Tübingen

+49 (0)7071 8597673


In order to be able to design our website in the best possible way and to continuously improve it, we are using cookies. By continuing to use our website, you permit the use of cookies. More information can be found in our data protection rules.